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An increased risk for late-occurring ischemic heart dis-
eases is a known consequence of a high dose radiation 
exposure to the heart [1]. Yet, there is growing evidence 
coming from epidemiological data for an increased risk at 
low doses [2]. To address the question whether the elec-
trophysiology of the heart is affected by ionizing radia-
tion, we used mouse embryonic stem cell (mESC)-
derived cardiomyocytes as a model system. Cells were 
cultured on a microelectrode arrays (MEA) enabling elec-
trophysiological measurements [3] and the effects of X-
rays and C-ions were examined. 
 
Briefly, commercially available purified mESC-derived 
cardiomyocytes (Cor.At, Axiogenesis) that build up spon-
taneously beating networks were used for experiments. 
Cor.At cells were seeded on the fibronectin-coated MEAs 
according to the manufacturer’s protocol. Radiation expo-
sure was performed two days after seeding applying ei-
ther C-ions (SOBP, twelve energies ranging from 107-
147 MeV/u, mean LET = 75 keV/µm at target position) 
accelerated at the SIS18 (GSI) or 250 kV X-rays. The 
doses used for both radiation qualities were 0.5 and 2 Gy. 
Measurements were conducted up to six days following 
exposure. Data were subsequently analyzed with the 
MATLAB-based software DrCell developed at University 
of Applied Sciences Aschaffenburg [4]. Electrophysiolog-
ical endpoints such as number of active electrodes, beat 
rate, the QT-interval-like section or the conduction ve-
locity were determined. 
Generally, inter-experimental variations were large. 
Therefore the data sets were not pooled. In figures 1 and 2 
data on the number of active electrodes and the beat rate 
measured two days after exposure to 2 Gy X-rays or C-
ions are exemplarily shown. As depicted in figure 1, in 
each experiment the number of active electrodes was not 
significantly changed in the irradiated samples compared 
to the control. The inter-experimental difference in the 
number of active electrodes between both data sets was 
pronounced (mean values of 46 and 19 active electrodes 
for the X-ray and the C-ion experiment, respectively). As 
shown in figure 2, also the beat rate was not affected by 
exposure to X-rays or C-ions when compared to the re-
spective controls. Notably, inter-experimental variations 
of the beat-rate were lower than those observed for the 
number of active electrodes (about 40 vs. 60 beats/min). 
Similarly, the QT-interval-like section of the cardiomyo-
cytes’ signal and their conduction velocities were not al-
tered after exposure (data not shown). 
 
Altogether our data show that electrophysiological pa-
rameters of cardiomyoctes were not affected at two days 
after exposure to X-rays or C-ions. Currently, measure-
ments performed at later time-points are analyzed to 
screen for putative effects occurring at later stages. 
 
 
Fig. 1: Number of active electrodes. Measurements were 
performed two days after exposure to 2 Gy of X-rays or 
C-ions, respectively (mean values ± SD of a total n ≥ 8). 
 
 
Fig. 2: Beat rate. Measurements were performed two days 
after exposure to 2 Gy of X-rays or C-ions, respectively 
(mean values ± SD of a total n ≥ 8). 
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